Literature DB >> 17151330

NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure.

Mary C Perianayagam1, Orfeas Liangos, Alexey Y Kolyada, Ron Wald, Robert W MacKinnon, Lijun Li, Madhumati Rao, Vaidyanathapuram S Balakrishnan, Joseph V Bonventre, Brian J Pereira, Bertrand L Jaber.   

Abstract

Reactive oxygen species are important mediators of injury in acute renal failure (ARF). Although polymorphisms that affect key pro- and antioxidant enzymes might alter the susceptibility to oxidative stress-mediated injury, the use of genetic epidemiology for the study of oxidative stress-related genes has received little attention in ARF. The relationship of single-nucleotide polymorphisms in the coding region (C to T substitution at position +242) of the pro-oxidant enzyme NADPH oxidase p22phox subunit gene and in the promoter region (C to T substitution at position -262) of the antioxidant enzyme catalase gene to adverse clinical outcomes was evaluated prospectively in a cohort of 200 hospitalized patients with established ARF of mixed cause and severity. Genomic DNA was extracted from peripheral blood leukocytes and analyzed with a restriction fragment length polymorphism PCR method. Genotype-phenotype associations were characterized by measuring circulating nitrotyrosine and catalase activity. Observed and expected genotype frequencies were not significantly different, and overall baseline characteristics were not significantly different according to the various genotype groups. A genotype-phenotype association was demonstrable between the NADPH oxidase p22phox genotypes and plasma nitrotyrosine level (P = 0.06), as well as between the catalase genotypes and whole-blood catalase activity (P < 0.001). Compared with the NADPH oxidase p22phox CC genotype group, the T-allele group had a higher cumulative probability of remaining hospitalized (P = 0.03). Compared with the NADPH oxidase p22phox CC genotype, the T-allele carrier state was associated with 2.1-fold higher odds for dialysis requirement or hospital death (P = 0.01). This association persisted with 2.0- to 2.2-fold higher odds for this composite outcome after adjustment for race; gender; age; and the Acute Physiology and Chronic Health Evaluation II score (P = 0.03), the Multiple Organ Failure score (P = 0.01), or presence of sepsis (P = 0.02). The polymorphism in the gene that encodes the NADPH oxidase p22phox subunit at position +242 is associated with dialysis requirement or hospital death among patients with ARF. Larger studies are needed to confirm these relationships.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151330     DOI: 10.1681/ASN.2006070806

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  36 in total

1.  Polymorphic variations in manganese superoxide dismutase (MnSOD), glutathione peroxidase-1 (GPX1), and catalase (CAT) contribute to elevated plasma triglyceride levels in Chinese patients with type 2 diabetes or diabetic cardiovascular disease.

Authors:  Hong Chen; Ming Yu; Ming Li; Ruie Zhao; Qihan Zhu; Wenrui Zhou; Ming Lu; Yufeng Lu; Taishan Zheng; Jiamei Jiang; Weijing Zhao; Kunsan Xiang; Weiping Jia; Limei Liu
Journal:  Mol Cell Biochem       Date:  2011-12-14       Impact factor: 3.396

2.  Protective role of extracellular superoxide dismutase in renal ischemia/reperfusion injury.

Authors:  Markus P Schneider; Jennifer C Sullivan; Paul F Wach; Erika I Boesen; Tatsuo Yamamoto; Tohru Fukai; David G Harrison; David M Pollock; Jennifer S Pollock
Journal:  Kidney Int       Date:  2010-05-26       Impact factor: 10.612

3.  CYBA (p22phox) variants associate with blood pressure and oxidative stress markers in hypertension: a replication study in populations of diverse altitudes.

Authors:  Rahul Kumar; Samantha Kohli; Zahara Ali; Kanika Duhan; Rekhbala Ram; Mohit Gupta; Sanjay Tyagi; Ghulam Mohammad; Ma Qadar Pasha
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

4.  Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes.

Authors:  Kamel Mohammedi; Thiago A Patente; Naïma Bellili-Muñoz; Fathi Driss; Maria Beatriz Monteiro; Ronan Roussel; Elizabeth J Pavin; Nathalie Seta; Frédéric Fumeron; Mirela J Azevedo; Luis H Canani; Samy Hadjadj; Michel Marre; Maria Lúcia Corrêa-Giannella; Gilberto Velho
Journal:  Diabetologia       Date:  2013-09-21       Impact factor: 10.122

Review 5.  Delayed graft function in the kidney transplant.

Authors:  A Siedlecki; W Irish; D C Brennan
Journal:  Am J Transplant       Date:  2011-09-19       Impact factor: 8.086

6.  Nicotinamide adenine dinucleotide phosphate oxidase is differentially regulated in normal myometrium versus leiomyoma.

Authors:  Nicole M Fletcher; Mohammed G Saed; Suleiman Abuanzeh; Husam M Abu-Soud; Ayman Al-Hendy; Michael P Diamond; Ghassan M Saed
Journal:  Reprod Sci       Date:  2014-02-11       Impact factor: 3.060

Review 7.  Cardiorenal syndrome: pathophysiology and potential targets for clinical management.

Authors:  Parta Hatamizadeh; Gregg C Fonarow; Matthew J Budoff; Sirous Darabian; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

Review 8.  Searching for genes that matter in acute kidney injury: a systematic review.

Authors:  Jonathan C T Lu; Steven G Coca; Uptal D Patel; Lloyd Cantley; Chirag R Parikh
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 8.237

9.  A genetic variant of hypoxia-inducible factor-1alpha is associated with adverse outcomes in acute kidney injury.

Authors:  Alexey Y Kolyada; Hocine Tighiouart; Mary C Perianayagam; Orfeas Liangos; Nicolaos E Madias; Bertrand L Jaber
Journal:  Kidney Int       Date:  2009-03-11       Impact factor: 10.612

10.  Phenylethanolamine N-methyltransferase gene polymorphisms and adverse outcomes in acute kidney injury.

Authors:  Ahsan Alam; Daniel T O'Connor; Mary C Perianayagam; Alexey Y Kolyada; Yuqing Chen; Fangwen Rao; Manjula Mahata; Sushil Mahata; Orfeas Liangos; Bertrand L Jaber
Journal:  Nephron Clin Pract       Date:  2010-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.